GLUL and acute lymphoblastic leukemia: Glutamine synthetase (GLUL), is of major interest, because this enzyme may be a resistance factor in metabolic cancer treatments; like the asparaginase treatment for acute lymphoblastic leukemia (ALL) and solid cancer (Rotoli et al., 2005).